ImClone Investigational Site

Toronto, Ontario M5G 2M9

0 studies enrolling now · 4 studies all time

What they study most

Breast Cancer, Colon Cancer, Colorectal Neoplasms, Metastases, Neoplasm, Rectal Cancer

Studies at this site

• Phase III Study of Docetaxel + Ramucirumab or Placebo in Breast Cancer — Completed
• Study of Icrucumab (IMC-18F1) or Ramucirumab Drug Product (DP) in Combination With Capecitabine or Capecitabine on Previously Treated Breast Cancer Patients — Completed
• A Study of Ramucirumab or Icrucumab in Colorectal Cancer — Completed
• Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to Chemotherapy — Completed